Global Heart Health Products Market Overview
Heart Health Products Market Size was valued at USD 17.6 Billion in 2023. The Heart Health Products industry is projected to grow from USD 18.77 Billion in 2024 to USD 29.5 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.81% during the forecast period (2024 - 2032). Increased awareness among consumers about a healthy lifestyle and rising cardiovascular diseases are the key market drivers enhancing the growth of market.
Source: The Secondary Research, Primary Research, MRFR Database, and Analyst Review
Heart Health Products Market Trends
- Growing awareness towards a healthy lifestyle is driving the market growth
Market CAGR for heart health products is being driven by the rising awareness of the population towards a healthy lifestyle. The rising adoption of high-quality foods that contribute to better health and consistent nutritional value has fueled the consumer's preference for healthy diet routines and lifestyle changes. The increased number of cases of cardiovascular diseases is one of the major factors leading to death. Thus consumers are opting for healthy living with healthy diets.
The growing awareness among consumers about the deteriorating effects of the consumption of products made out of harmful chemicals is driving healthy heart products. The presence of novel products helps specific requirements and needs while being easily accessible for heart health supplements. The sedentary lifestyle and eating habits lead to the prevalence of heart diseases, and the rising concerns about obesity have increased the sales of heart health supplements. The growing awareness about high-quality foods that helps to gain good health and consist of the nutritional value has led the consumer's inclination to healthy diet routine and lifestyle changes. Further, obesity is slowly becoming a concern for current consumers. Thus, the demand for supplements consisting of strong health benefits that further help the prevention of heart diseases is increasing.
The increasing aging population and increasing disposable income of various individuals are anticipated increase the consumption of heart health ingredients, thus boosting the growth of heart health products. The rapid development in technology is increasing the research initiatives that assist the heart health product market. The availability of solutions is helping the customers to obtain specific solutions to help in solving specific health requirements of the advances. Thus, driving the Heart Health Products market revenue.
However, the high cost of heart health products with strict regulatory approvals is hampering the full-fledged market growth. Additionally, the lack of awareness towards heart health products among the developing economies is anticipated to restrain the growth of heart health products.
Heart Healt Products Market Segment Insights
Heart Health Products Type Insights
The Heart Health Products market segmentation, based on type, includes Grains & Pulses, Fruits, and Vegetables. The grain and pulses segment dominates the market, accounting for the largest market revenue as they reduce blood pressure and enhance overall cardiovascular health. Grains and pulses are food that is plant-based, high in fiber, minerals, vitamins, and other crucial nutrients possessing various health benefits, like improved health of the heart. The consumption of legumes and grains also helps minimize cholesterol levels and minimizes coronary artery disease risk.
Heart Health Products Application Insights
The Heart Health Products market segmentation, based on application, includes Children and Adults. The children segment dominates the market segment due to the increasing awareness about the nutritional food of children, rising preference for cereals over other foods, and growing consumption of milk products and milk. Cholesterol levels in children can be reduced, which will be helpful in reducing the risk for heart diseases later in life, with heart health products consumption. It can also assist in enhancing overall cardiovascular health by giving essential nutrients beneficial for the heart, like omega-3 fatty acids and antioxidants. Heart health products can also reduce inflammation, which leads to heart diseases, improving the overall well-being of children. The adult segment is anticipated to witness the highest growth rate during the forecast period.
Figure 1: Heart Health Products Market, by Application, 2022 & 2032 (USD Billion)
Source: The Secondary Research, Primary Research, MRFR Database, and Analyst Review
Heart Health Products Regional Insights
By region, the study offers market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Heart Health Products market area dominates the market owing to the presence of key market players and rising awareness among consumers for preventive health care, and a growing number of consumers fighting lifestyle diseases. The largest contributor to the heart health product market is the US in the North American region.
Further, the prime countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, Japan, India, China, Australia, South Korea, and Brazil.
Figure 2: HEART HEALTH PRODUCTS MARKET SHARE BY REGION 2022 (USD Billion)
Source: The Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe's Heart Health Products market accounts for the second-largest market revenue due to the presence of well-established technologically advanced infrastructure and the rising awareness about healthy living among consumers. Further, the German Heart Health Products market held the largest market share, and the UK Heart Health Products market was the fastest-growing market in the European region.
The Asia-Pacific Heart Health Products Market is expected to grow at the rapid CAGR from 2023 to 2032. This is due to the presence of highly populated countries and the increasing per capita income of the individuals in the region. Moreover, China’s Heart Health Products market held the largest market share, and the Indian Heart Health Products market was the rapid-growing market in the Asia-Pacific region.
Heart Health Products Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Heart Health Products market grow even more. Market players are also undertaking various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Heart Health Products industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Heart Health Products industry to benefit clients and increase the market sector. In recent years, the Heart Health Products industry has offered some of the most significant advantages to the healthcare industry. Major players in the Heart Health Products market, including United Agricultural Services Laboratories, Koninklijke DSM NV, Kerry, USANA Health Science Inc., Nature’s Way Products Inc., Irwin Naturals, Asterism Healthcare Group, Advanced Orthomolecular Research, GNC Holdings Inc., Maritzmayer Laboratories Inc., and others, are trying to increase market demand by investing in research and development operations.
United Agricultural Services Laboratories, commonly known as UAS Laboratories, founded in the year 1979, and headquartered in Wisconsin, USA, is a private biotechnology company. The company formulates and markets probiotics for the domestic as well as international markets. The company offers trusted probiotic-based facilities via innovative applications of quality, science, and talent, which helps in healthy living while exceeding stakeholder expectations. The company's expertise in semi-finished and raw-material offerings of probiotic-based supplements and private labeling, offering biotechnology, emphasized research on the health of the humans and the healthcare industry. In 2020, UAS Laboratories LLC was acquired by Hansen Holdings AS in order to strengthen the human health business of the latter company. This acquisition will assist the company in improving its product portfolio of the company and will also expand the microbial platform and human health business.
Koninklijke DSM NV, a Dutch multinational corporation established in 1902, is a science-based company that emphasizes nutrition, health, and bioscience. The nutrition business of the company comprises DSM nutritional products and DSM food specialists. The company offers solutions for the people and planet's health and screens the sections like animal nutrition and health, beverage and food, medical nutrition, pharmaceuticals, nutrition improvements, early life nutrition, dietary supplements, and personal care. In 2019, KONINKLIJKE DSM NV acquired AVA in order to improve its position in the personalized nutrition section, as the company offers tailored solutions for heart health to its customers.
Key Companies in the Heart Health Products market include
- United Agricultural Services Laboratories
- Koninklijke DSM NV
- Kerry
- USANA Health Science Inc.
- Nature’s Way Products Inc.
- Irwin Naturals
- Asterism Healthcare Group
- Advanced Orthomolecular Research
- GNC Holdings Inc.
- Maritzmayer Laboratories Inc.
Heart Health Products Industry Developments
March 2024 –The Food and Drug Administration on March 23rd approved Wegovy manufacturer Novo Nordisk's application to add cardiovascular advantages to the weight-loss drug's label. The decision makes Wegovy the first weight-loss drug to be advertised to inhibit cardiovascular events such as heart attack or stroke. Novo Nordisk President Doug Langa said in a statement that they identify how crucial this moment is for the millions of people who live with extra weight or obesity and known heart disease. The company will continue to advance options that put their needs first. The label extension is anticipated to enhance insurance coverage for Wegovy -- the sister drug to Novo Nordisk's better-known Ozempic – which is worth more than USD1,300 per month out of pocket. Several insurers, including Medicare, don't cover drugs for weight loss. A cardiologist and scientist at Yale University and Yale New Haven Hospital, Dr. Harlan Krumholz, stated that the significance of Wegovy is "not about appearance but about health. " She said that the proof is that they lower the risk and save lives, so it is invalid to deny people access to medications that will directly improve their health. The FDA authorization is based on a 17,000-patient study that explained that people who took Wegovy had a 20% lower risk of cardiac events than people who took a placebo. Wegovy is shown for people who are considered obese -- body mass index of 30 -- or overweight -- BMI of 27 -- and have at least one "weight-related" condition such as high cholesterol or blood pressure. The director of the FDA's Division of Diabetes, Lipid Disorders, and Obesity, Dr. John Sharretts, said in a statement that this patient population has a greater risk of cardiovascular death, heart attack and stroke. He further said that offering a treatment option that is established to reduce this cardiovascular risk is a major advance for public health.
February 2022: The acquisition of Pharma foods international Co was announced by Kerry. This acquisition will fuel the manufacturing capabilities of the company.
January 2018: USANA Health Sciences Inc. started to expand its presence throughout Europe to increase its footprint. The company expanded its presence by opening subsidiaries in Romania, Germany, Spain, and Italy, from roughly 20 to 24 markets globally.
February 2017: By-Health and Koninklijke NV collaborated to introduce new cardiovascular health products consisting of tomato extract ingredients, Fruitflow. This collaboration will help the company to meet the regulations and standards of China.
Heart Health Products Market Segmentation
Heart Health Products Type Outlook
- Grains & Pulses
- Fruits
- Vegetables
Heart Health Products Application Outlook
Heart Health Products Regional Outlook
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Attribute/Metric |
Details |
Market Size 2023 |
USD 17.6 Billion |
Market Size 2024 |
USD 18.77 Billion |
Market Size 2032 |
USD 29.5 Billion |
Compound Annual Growth Rate (CAGR) |
5.81% (2024-2032) |
Base Year |
2023 |
Market Forecast Period |
2024-2032 |
Historical Data |
2018- 2022 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Type, Application, and Region |
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
Countries Covered |
The US, Canada, German, France, UK, Italy, Spain, Japan, India, China, Australia, South Korea, and Brazil |
Key Companies Profiled |
United Agricultural Services Laboratories, Koninklijke DSM NV, Kerry, USANA Health Science Inc., Nature’s Way Products Inc., Irwin Naturals, Asterism Healthcare Group, Advanced Orthomolecular Research, GNC Holdings Inc., Maritzmayer Laboratories Inc.  |
Key Market Opportunities |
Rising prevalence of cardiovascular diseases. |
Key Market Dynamics |
Increased awareness among consumers towards healthy lifestyles. |
Heart Health Products Market Highlights:
Frequently Asked Questions (FAQ) :
The Hearth Health Products market size was valued at USD 17.6 Billion in 2023.
The market is foreseen to grow at a CAGR of 5.81% during the forecast period, 2024-2032.
North America had the largest share of the market
The key players in the market are United Agricultural Services Laboratories, Koninklijke DSM NV, Kerry, USANA Health Science Inc., Nature’s Way Products Inc., Irwin Naturals, Asterism Healthcare Group, Advanced Orthomolecular Research, GNC Holdings Inc., Maritzmayer Laboratories Inc.
The grain and pulses category dominated the market in 2023.
The child category had the largest share in the market.